부산대학교 도서관

Armenia J; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Wankowicz SAM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Liu D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Gao J; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Kundra R; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Reznik E; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Chatila WK; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Chakravarty D; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Han GC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Coleman I; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Montgomery B; Department of Medicine, University of Washington, Seattle, WA, USA.; Pritchard C; Department of Laboratory Medicine, University of Washington, Seattle, WA, USA.; Morrissey C; Department of Urology, University of Washington, Seattle, WA, USA.; Barbieri CE; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.; Beltran H; Department of Medicine, Division of Medical Oncology, Weill Cornell Medicine, New York, NY, USA.; Englander Institute for Precision Medicine, Weill Cornell Medical College-New York Presbyterian Hospital, New York, NY, USA.; Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College, New York, NY, USA.; Sboner A; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.; Zafeiriou Z; Biomarkers Team, Division of Clinical Studies, The Institute of Cancer Research and Royal Marsden Hospital, London, UK.; Miranda S; Biomarkers Team, Division of Clinical Studies, The Institute of Cancer Research and Royal Marsden Hospital, London, UK.; Bielski CM; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Penson AV; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Tolonen C; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Huang FW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Robinson D; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.; Wu YM; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.; Lonigro R; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.; Garraway LA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Demichelis F; Centre for Integrated Biology, University of Trento, Trento, Italy.; Kantoff PW; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Taplin ME; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Abida W; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Taylor BS; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Scher HI; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Nelson PS; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Medicine, University of Washington, Seattle, WA, USA.; de Bono JS; Biomarkers Team, Division of Clinical Studies, The Institute of Cancer Research and Royal Marsden Hospital, London, UK.; Rubin MA; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.; Englander Institute for Precision Medicine, Weill Cornell Medical College-New York Presbyterian Hospital, New York, NY, USA.; Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College, New York, NY, USA.; Sawyers CL; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Chinnaiyan AM; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.; Schultz N; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. schultzn@mskcc.org.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. schultzn@mskcc.org.; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. schultzn@mskcc.org.; Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. eliezerm_vanallen@dfci.harvard.edu.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA. eliezerm_vanallen@dfci.harvard.edu.

Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: PubMed not MEDLINE

McKay RR; University of California San Diego, San Diego, California.; Dana-Farber Cancer Institute, Boston, Massachusetts.; Bossé D; Dana-Farber Cancer Institute, Boston, Massachusetts.; Xie W; Dana-Farber Cancer Institute, Boston, Massachusetts.; Wankowicz SAM; Dana-Farber Cancer Institute, Boston, Massachusetts.; Flaifel A; Brigham and Women's Hospital, Boston, Massachusetts.; Brandao R; Dana-Farber Cancer Institute, Boston, Massachusetts.; Lalani AA; Dana-Farber Cancer Institute, Boston, Massachusetts.; Martini DJ; Dana-Farber Cancer Institute, Boston, Massachusetts.; Wei XX; Dana-Farber Cancer Institute, Boston, Massachusetts.; Braun DA; Dana-Farber Cancer Institute, Boston, Massachusetts.; Van Allen E; Dana-Farber Cancer Institute, Boston, Massachusetts.; Castellano D; Hospital Universitario 12 de Octubre, Madrid, Spain (CiberOnc).; De Velasco G; Hospital Universitario 12 de Octubre, Madrid, Spain (CiberOnc).; Wells JC; Tom Baker Cancer Center, Calgary, Canada.; Heng DY; Tom Baker Cancer Center, Calgary, Canada.; Fay AP; Pontificia Universidade Católica do Rio Grande do Sul School of Medicine, Porto Alegre, Brazil.; Schutz FA; Beneficencia Portuguesa de São Paulo, São Paulo, Brazil.; Hsu J; City of Hope Comprehensive Cancer Center, Duarte, California.; Pal SK; City of Hope Comprehensive Cancer Center, Duarte, California.; Lee JL; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.; Hsieh JJ; Siteman Cancer Center, Washington University, St. Louis, Missouri.; Harshman LC; Dana-Farber Cancer Institute, Boston, Massachusetts.; Signoretti S; Brigham and Women's Hospital, Boston, Massachusetts.; Motzer RJ; Memorial Sloan Kettering Cancer Center, New York, New York.; Feldman D; Memorial Sloan Kettering Cancer Center, New York, New York.; Choueiri TK; Dana-Farber Cancer Institute, Boston, Massachusetts. Toni_Choueiri@DFCI.HARVARD.EDU.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

Armenia J; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Wankowicz SAM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Liu D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Gao J; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Kundra R; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Reznik E; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Chatila WK; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Chakravarty D; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Han GC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Coleman I; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Montgomery B; Department of Medicine, University of Washington, Seattle, WA, USA.; Pritchard C; Department of Laboratory Medicine, University of Washington, Seattle, WA, USA.; Morrissey C; Department of Urology, University of Washington, Seattle, WA, USA.; Barbieri CE; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.; Beltran H; Department of Medicine, Division of Medical Oncology, Weill Cornell Medicine, New York, NY, USA.; Englander Institute for Precision Medicine, Weill Cornell Medical College-New York Presbyterian Hospital, New York, NY, USA.; Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College, New York, NY, USA.; Sboner A; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.; Zafeiriou Z; Biomarkers Team, Division of Clinical Studies, The Institute of Cancer Research and Royal Marsden Hospital, London, UK.; Miranda S; Biomarkers Team, Division of Clinical Studies, The Institute of Cancer Research and Royal Marsden Hospital, London, UK.; Bielski CM; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Penson AV; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Tolonen C; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Huang FW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Robinson D; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.; Wu YM; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.; Lonigro R; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.; Garraway LA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Demichelis F; Centre for Integrated Biology, University of Trento, Trento, Italy.; Kantoff PW; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Taplin ME; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Abida W; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Taylor BS; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Scher HI; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Nelson PS; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Medicine, University of Washington, Seattle, WA, USA.; de Bono JS; Biomarkers Team, Division of Clinical Studies, The Institute of Cancer Research and Royal Marsden Hospital, London, UK.; Rubin MA; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.; Englander Institute for Precision Medicine, Weill Cornell Medical College-New York Presbyterian Hospital, New York, NY, USA.; Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College, New York, NY, USA.; Sawyers CL; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Chinnaiyan AM; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.; Schultz N; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. schultzn@mskcc.org.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. schultzn@mskcc.org.; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. schultzn@mskcc.org.; Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. eliezerm_vanallen@dfci.harvard.edu.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA. eliezerm_vanallen@dfci.harvard.edu.

Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE

Han GC; , , , , , , , and , Dana-Farber Cancer Institute; , , , and , Brigham and Women's Hospital; and , Beth Israel Deaconess Medical Center, Boston; , , , , , , , and , Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA; and , University of California San Diego, La Jolla, CA.; Hwang J; , , , , , , , and , Dana-Farber Cancer Institute; , , , and , Brigham and Women's Hospital; and , Beth Israel Deaconess Medical Center, Boston; , , , , , , , and , Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA; and , University of California San Diego, La Jolla, CA.; Wankowicz SAM; , , , , , , , and , Dana-Farber Cancer Institute; , , , and , Brigham and Women's Hospital; and , Beth Israel Deaconess Medical Center, Boston; , , , , , , , and , Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA; and , University of California San Diego, La Jolla, CA.; Zhang Z; , , , , , , , and , Dana-Farber Cancer Institute; , , , and , Brigham and Women's Hospital; and , Beth Israel Deaconess Medical Center, Boston; , , , , , , , and , Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA; and , University of California San Diego, La Jolla, CA.; Liu D; , , , , , , , and , Dana-Farber Cancer Institute; , , , and , Brigham and Women's Hospital; and , Beth Israel Deaconess Medical Center, Boston; , , , , , , , and , Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA; and , University of California San Diego, La Jolla, CA.; Cibulskis C; , , , , , , , and , Dana-Farber Cancer Institute; , , , and , Brigham and Women's Hospital; and , Beth Israel Deaconess Medical Center, Boston; , , , , , , , and , Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA; and , University of California San Diego, La Jolla, CA.; Gaviola GC; , , , , , , , and , Dana-Farber Cancer Institute; , , , and , Brigham and Women's Hospital; and , Beth Israel Deaconess Medical Center, Boston; , , , , , , , and , Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA; and , University of California San Diego, La Jolla, CA.; Ghazikhanian V; , , , , , , , and , Dana-Farber Cancer Institute; , , , and , Brigham and Women's Hospital; and , Beth Israel Deaconess Medical Center, Boston; , , , , , , , and , Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA; and , University of California San Diego, La Jolla, CA.; McKay RR; , , , , , , , and , Dana-Farber Cancer Institute; , , , and , Brigham and Women's Hospital; and , Beth Israel Deaconess Medical Center, Boston; , , , , , , , and , Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA; and , University of California San Diego, La Jolla, CA.; Bubley GJ; , , , , , , , and , Dana-Farber Cancer Institute; , , , and , Brigham and Women's Hospital; and , Beth Israel Deaconess Medical Center, Boston; , , , , , , , and , Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA; and , University of California San Diego, La Jolla, CA.; Carter SL; , , , , , , , and , Dana-Farber Cancer Institute; , , , and , Brigham and Women's Hospital; and , Beth Israel Deaconess Medical Center, Boston; , , , , , , , and , Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA; and , University of California San Diego, La Jolla, CA.; Balk SP; , , , , , , , and , Dana-Farber Cancer Institute; , , , and , Brigham and Women's Hospital; and , Beth Israel Deaconess Medical Center, Boston; , , , , , , , and , Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA; and , University of California San Diego, La Jolla, CA.; Hahn WC; , , , , , , , and , Dana-Farber Cancer Institute; , , , and , Brigham and Women's Hospital; and , Beth Israel Deaconess Medical Center, Boston; , , , , , , , and , Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA; and , University of California San Diego, La Jolla, CA.; Taplin ME; , , , , , , , and , Dana-Farber Cancer Institute; , , , and , Brigham and Women's Hospital; and , Beth Israel Deaconess Medical Center, Boston; , , , , , , , and , Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA; and , University of California San Diego, La Jolla, CA.; Van Allen EM; , , , , , , , and , Dana-Farber Cancer Institute; , , , and , Brigham and Women's Hospital; and , Beth Israel Deaconess Medical Center, Boston; , , , , , , , and , Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA; and , University of California San Diego, La Jolla, CA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: eCollection Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: PubMed not MEDLINE

Sevillano E; Comprehensive Cancer Center Clara Campal (CIOCC), Madrid, Spain.; Werner L; Biostatistics and Computational Biology, Harvard Medical School, Boston, MA.; Bossé D; Dana-Farber Cancer Institute, Boston, MA.; Lalani AA; Dana-Farber Cancer Institute, Boston, MA.; Wankowicz SAM; Dana-Farber Cancer Institute, Boston, MA.; de Velasco G; University Hospital 12 De Octubre, Medical Oncology, Madrid, Spain.; Farina M; Dana-Farber Cancer Institute, Boston, MA.; Lundgren K; Dana-Farber Cancer Institute, Boston, MA.; Choueiri TK; Dana-Farber Cancer Institute, Boston, MA.; González Del Alba A; University Hospital Son Espases, Palma de Mallorca, Spain.; Bellmunt J; Dana-Farber Cancer Institute, Boston, MA; Hospital De Mar Research Institute-IMIM, Barcelona, Spain. Electronic address: joaquim_bellmunt@dfci.harvard.edu.

Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE

Vetterlein MW; Division of Urological Surgery, Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Wankowicz SAM; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Seisen T; Division of Urological Surgery, Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Urology, Pitié-Salpêtriére Hospital, Pierre and Marie Curie University, Paris, France.; Lander R; Division of Urological Surgery, Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Löppenberg B; Division of Urological Surgery, Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Urology, Marien Hospital Herne, Ruhr-University Bochum, Herne, Germany.; Chun FK; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Menon M; Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan.; Sun M; Division of Urological Surgery, Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Barletta JA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Choueiri TK; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Bellmunt J; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Trinh QD; Division of Urological Surgery, Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Preston MA; Division of Urological Surgery, Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Wankowicz SAM; Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts.; Werner L; Department of Biostatistics, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts.; Orsola A; Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts.; Novak J; Department of Pathology, Brigham and Women's Cancer Center, Boston, Massachusetts.; Bowden M; Department of Medical Oncology, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts.; Choueiri TK; Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.; de Torres I; Department of Pathology, Vall d'Hebron Hospital, Barcelona, Spain.; Morote J; Department of Urology, Vall d'Hebron Hospital, Barcelona, Spain.; Freeman GJ; Department of Medical Oncology, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.; Signoretti S; Department of Pathology, Brigham and Women's Cancer Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.; Bellmunt J; Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. Electronic address: Joaquim_bellmunt@dfci.harvard.edu.

Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 0376374 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3792 (Electronic) Linking ISSN: 00225347 NLM ISO Abbreviation: J Urol Subsets: MEDLINE